Abstract There has been limited success with blood-based biomarkers of neurodegeneration. One perceived reason is that blood has no direct contact to the brain. Recently developed blood-based biomarkers of tau-degradation have shown promise as potential tools for peripheral assessment of neurodegeneration; however, factors contributing to the levels of these in blood are poorly understood. Using […]
Modifiable risk factors promoting neurodegeneration is associated with two novel brain degradation markers measured in serum.
September 1, 2017
Neurochem Int